CHRISTOPHER WILSON: Open Payments
NPI 1073136784 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 107 payments from 17 companies in 2025. Trend: 2023 $1,472 · 2024 $1,391 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $248 |
| Medtronic, Inc. | 12 | $226 |
| Lilly USA, LLC | 14 | $223 |
| Radius Health, Inc. | 18 | $191 |
| Tandem Diabetes Care, Inc. | 6 | $131 |
| BETA BIONICS, INC. | 8 | $125 |
| Xeris Pharmaceuticals, Inc. | 5 | $110 |
| Dexcom, Inc. | 3 | $99 |
| Ascendis Pharma Endocrinology Inc | 3 | $62 |
| Corcept Therapeutics | 2 | $47 |
Products named: MINIMED 780G, Tymlos, Ozempic, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, GVOKE HYPOPEN, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
